Cite
MLA Citation
Y Tanaka et al.. “FRI0214 Long-term efficacy and safety of sirukumab in patients with active rheumatoid arthritis despite anti-tumor necrosis factor therapy: results of the randomized, phase 3 sirround-t study.” Annals of the rheumatic diseases, vol. 76, n.d., pp. 563–564. http://access.bl.uk/ark:/81055/vdc_100135160318.0x00005f